Extract notice to the Minister
Bimzelx (hidradénite suppurée)
Common name / Subject : bimekizumab
Name of the manufacturer : U.C.B.
Form : Sol. Inj. S.C. (stylo); Sol. Inj. S.C. (ser)
Dosage : stylo : 160 mg/ml (1 ml), 160 mg/ml (2 ml); ser : 160 mg/ml (1 ml), 160 mg/ml (2 ml)
Name of the manufacturer : U.C.B.
Form : Sol. Inj. S.C. (stylo); Sol. Inj. S.C. (ser)
Dosage : stylo : 160 mg/ml (1 ml), 160 mg/ml (2 ml); ser : 160 mg/ml (1 ml), 160 mg/ml (2 ml)
Indication : Hidradénite suppurée
INESSS' Recommendation
Inscription - Sous conditions
Minister's decisions
Surseoir à la décision (2026-03-04)
Evaluation published on March 04, 2026
INESSSid: 25180
Recevable on November 11, 2024